Drug Profile
Aderon - Defyrus
Alternative Names: Aderon; DEF 201 + vaccine - DefyrusLatest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator Defyrus
- Class Interferons; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Viral infections (Prevention) in Canada (Parenteral)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Viral-infections(Prevention) in Canada (Parenteral)
- 07 Jul 2016 Preclinical trials in Viral infections (Prevention) in Canada (Parenteral)